ID   APX_STRGG               Reviewed;         445 AA.
AC   P80561; B1W291;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   26-NOV-2014, sequence version 2.
DT   22-JUL-2015, entry version 90.
DE   RecName: Full=Aminopeptidase S;
DE            EC=3.4.11.24;
DE   AltName: Full=API {ECO:0000303|PubMed:2503378};
DE   AltName: Full=SGAP {ECO:0000303|PubMed:9048953};
DE   Flags: Precursor;
GN   OrderedLocusNames=SGR_5809;
OS   Streptomyces griseus subsp. griseus (strain JCM 4626 / NBRC 13350).
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces.
OX   NCBI_TaxID=455632;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JCM 4626 / NBRC 13350;
RX   PubMed=18375553; DOI=10.1128/JB.00204-08;
RA   Ohnishi Y., Ishikawa J., Hara H., Suzuki H., Ikenoya M., Ikeda H.,
RA   Yamashita A., Hattori M., Horinouchi S.;
RT   "Genome sequence of the streptomycin-producing microorganism
RT   Streptomyces griseus IFO 13350.";
RL   J. Bacteriol. 190:4050-4060(2008).
RN   [2]
RP   PROTEIN SEQUENCE OF 46-329, FUNCTION, AND MASS SPECTROMETRY.
RX   PubMed=8665903; DOI=10.1111/j.1432-1033.1996.00843.x;
RA   Maras B., Greenblatt H.M., Shoham G., Spungin-Bialik A., Blumberg S.,
RA   Barra D.;
RT   "Aminopeptidase from Streptomyces griseus: primary structure and
RT   comparison with other zinc-containing aminopeptidases.";
RL   Eur. J. Biochem. 236:843-846(1996).
RN   [3]
RP   PROTEIN SEQUENCE OF 46-51, FUNCTION, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, AND
RP   THERMAL STABILITY.
RX   PubMed=2503378; DOI=10.1111/j.1432-1033.1989.tb14952.x;
RA   Spungin A., Blumberg S.;
RT   "Streptomyces griseus aminopeptidase is a calcium-activated zinc
RT   metalloprotein. Purification and properties of the enzyme.";
RL   Eur. J. Biochem. 183:471-477(1989).
RN   [4]
RP   CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR, ENZYME
RP   REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8444149; DOI=10.1111/j.1432-1033.1993.tb17639.x;
RA   Ben-Meir D., Spungin A., Ashkenazi R., Blumberg S.;
RT   "Specificity of Streptomyces griseus aminopeptidase and modulation of
RT   activity by divalent metal ion binding and substitution.";
RL   Eur. J. Biochem. 212:107-112(1993).
RN   [5]
RP   SEQUENCE REVISION TO 115 AND 229, FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, POSSIBLE REACTION MECHANISM, ACTIVE SITE, MUTAGENESIS OF
RP   GLU-176 AND TYR-291, AND EXPRESSION IN E.COLI.
RC   STRAIN=DSM 40855;
RX   PubMed=15280041; DOI=10.1016/j.febslet.2004.07.001;
RA   Fundoiano-Hershcovitz Y., Rabinovitch L., Langut Y., Reiland V.,
RA   Shoham G., Shoham Y.;
RT   "Identification of the catalytic residues in the double-zinc
RT   aminopeptidase from Streptomyces griseus.";
RL   FEBS Lett. 571:192-196(2004).
RN   [6]
RP   FUNCTION, ENZYME REGULATION, REACTION MECHANISM, AND ACTIVE SITE.
RX   PubMed=17608735; DOI=10.1111/j.1742-4658.2007.05912.x;
RA   Hershcovitz Y.F., Gilboa R., Reiland V., Shoham G., Shoham Y.;
RT   "Catalytic mechanism of SGAP, a double-zinc aminopeptidase from
RT   Streptomyces griseus.";
RL   FEBS J. 274:3864-3876(2007).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH CALCIUM AND
RP   ZINC, COFACTOR, SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=9048953; DOI=10.1006/jmbi.1996.0729;
RA   Greenblatt H.M., Almog O., Maras B., Spungin-Bialik A., Barra D.,
RA   Blumberg S., Shoham G.;
RT   "Streptomyces griseus aminopeptidase: X-ray crystallographic structure
RT   at 1.75-A resolution.";
RL   J. Mol. Biol. 265:620-636(1997).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.30 ANGSTROMS) IN COMPLEX WITH CALCIUM AND
RP   ZINC AND INHIBITORS, COFACTOR, ENZYME REGULATION, SUBUNIT, AND
RP   DISULFIDE BOND.
RX   PubMed=15388919; DOI=10.1107/S0907444904018281;
RA   Reiland V., Gilboa R., Spungin-Bialik A., Schomburg D., Shoham Y.,
RA   Blumberg S., Shoham G.;
RT   "Binding of inhibitory aromatic amino acids to Streptomyces griseus
RT   aminopeptidase.";
RL   Acta Crystallogr. D 60:1738-1746(2004).
CC   -!- FUNCTION: An exopeptidase specific for larger hydrophobic amino
CC       acids (especially leucine), no cleavage occurs if the next residue
CC       is proline (PubMed:8444149). {ECO:0000269|PubMed:2503378,
CC       ECO:0000269|PubMed:8444149, ECO:0000269|PubMed:8665903}.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal amino acid with a
CC       preference for large hydrophobic amino-terminus residues.
CC       {ECO:0000269|PubMed:8444149}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:15388919,
CC         ECO:0000269|PubMed:9048953};
CC       Note=Binds 1 Ca(2+) per subunit. {ECO:0000269|PubMed:15388919,
CC       ECO:0000269|PubMed:9048953};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15388919,
CC         ECO:0000269|PubMed:8444149, ECO:0000269|PubMed:9048953};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:8444149};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:8444149};
CC       Note=Binds 2 Zn(2+) ions per subunit. Can be replaced by Mn(2+) or
CC       Co(2+) which results in altered specificities (PubMed:8444149).
CC       {ECO:0000269|PubMed:15388919, ECO:0000269|PubMed:8444149,
CC       ECO:0000269|PubMed:9048953};
CC   -!- ENZYME REGULATION: Calcium activates the enzyme, inhibited by
CC       1,10-phenanthroline, EDTA and EGTA (PubMed:2503378). End-product
CC       inhibited by L-amino acids (PubMed:15388919). Non-competitively
CC       inhibited by NaF and NaH(2)PO(4) (PubMed:17608735).
CC       {ECO:0000269|PubMed:15388919, ECO:0000269|PubMed:17608735,
CC       ECO:0000269|PubMed:2503378, ECO:0000269|PubMed:8444149}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.59 mM for Leu-NH-Np (with zinc as cofactor)
CC         {ECO:0000269|PubMed:8444149};
CC         KM=0.13 mM for Leu-NH-Np (with manganese as cofactor)
CC         {ECO:0000269|PubMed:8444149};
CC         KM=0.046 mM for Leu-NH-Np (with cobalt as cofactor)
CC         {ECO:0000269|PubMed:8444149};
CC         KM=4.1 mM for Ala-NH-Np (with zinc as cofactor)
CC         {ECO:0000269|PubMed:8444149};
CC         KM=1.74 mM for Ala-NH-Np (with cobalt as cofactor)
CC         {ECO:0000269|PubMed:8444149};
CC         KM=0.57 mM for Leu-pNA (with zinc as cofactor)
CC         {ECO:0000269|PubMed:15280041};
CC         Note=kcat is 390 s(-1) with Leu-pNA.
CC         {ECO:0000269|PubMed:15280041};
CC       Temperature dependence:
CC         Stable after heating at 69 degrees Celsius for 5 hours.
CC         {ECO:0000269|PubMed:2503378};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:2503378,
CC       ECO:0000269|PubMed:9048953}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:2503378,
CC       ECO:0000269|PubMed:8665903}.
CC   -!- MASS SPECTROMETRY: Mass=29728; Mass_error=1.0;
CC       Method=Electrospray; Range=46-329;
CC       Evidence={ECO:0000269|PubMed:8665903};
CC   -!- BIOTECHNOLOGY: Sold by several companies as an extracellular
CC       extract called Pronase. {ECO:0000305|PubMed:2503378,
CC       ECO:0000305|PubMed:8444149, ECO:0000305|PubMed:8665903}.
CC   -!- MISCELLANEOUS: Most experiments use protein purified from a
CC       commercial source rather than protein that has been overexpressed.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the peptidase M28 family. M28A subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP009493; BAG22638.1; -; Genomic_DNA.
DR   PIR; S66427; S66427.
DR   RefSeq; WP_012381549.1; NC_010572.1.
DR   PDB; 1CP7; X-ray; 1.58 A; A=46-329.
DR   PDB; 1F2O; X-ray; 1.70 A; A=46-329.
DR   PDB; 1F2P; X-ray; 1.80 A; A=46-329.
DR   PDB; 1QQ9; X-ray; 1.53 A; A=46-329.
DR   PDB; 1TF8; X-ray; 1.30 A; A=46-329.
DR   PDB; 1TF9; X-ray; 1.30 A; A=46-329.
DR   PDB; 1TKF; X-ray; 1.20 A; A=46-329.
DR   PDB; 1TKH; X-ray; 1.25 A; A=46-329.
DR   PDB; 1TKJ; X-ray; 1.15 A; A=46-329.
DR   PDB; 1XBU; X-ray; 1.20 A; A=46-322.
DR   PDB; 1XJO; X-ray; 1.75 A; A=46-329.
DR   PDBsum; 1CP7; -.
DR   PDBsum; 1F2O; -.
DR   PDBsum; 1F2P; -.
DR   PDBsum; 1QQ9; -.
DR   PDBsum; 1TF8; -.
DR   PDBsum; 1TF9; -.
DR   PDBsum; 1TKF; -.
DR   PDBsum; 1TKH; -.
DR   PDBsum; 1TKJ; -.
DR   PDBsum; 1XBU; -.
DR   PDBsum; 1XJO; -.
DR   ProteinModelPortal; P80561; -.
DR   SMR; P80561; 46-322.
DR   STRING; 455632.SGR_5809; -.
DR   MEROPS; M28.003; -.
DR   EnsemblBacteria; BAG22638; BAG22638; SGR_5809.
DR   GeneID; 6210128; -.
DR   KEGG; sgr:SGR_5809; -.
DR   PATRIC; 23758425; VBIStrGri32265_5952.
DR   HOGENOM; HOG000268660; -.
DR   OMA; SDHAAFA; -.
DR   OrthoDB; EOG68DCWW; -.
DR   BioCyc; SGRI455632:GD3A-5884-MONOMER; -.
DR   BRENDA; 3.4.11.24; 6035.
DR   SABIO-RK; P80561; -.
DR   EvolutionaryTrace; P80561; -.
DR   Proteomes; UP000001685; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   Gene3D; 2.60.120.260; -; 1.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR002884; PrprotnconvertsP.
DR   Pfam; PF01483; P_proprotein; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminopeptidase; Calcium; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Hydrolase; Metal-binding;
KW   Protease; Reference proteome; Secreted; Signal; Zinc; Zymogen.
FT   SIGNAL        1     45       {ECO:0000269|PubMed:2503378,
FT                                ECO:0000269|PubMed:8665903}.
FT   CHAIN        46    329       Aminopeptidase S.
FT                                /FTId=PRO_0000174143.
FT   PROPEP      330    445       Removed in mature form.
FT                                {ECO:0000269|PubMed:8665903}.
FT                                /FTId=PRO_0000431389.
FT   ACT_SITE    176    176       Proton acceptor.
FT                                {ECO:0000303|PubMed:15280041,
FT                                ECO:0000303|PubMed:17608735}.
FT   METAL        48     48       Calcium. {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL        49     49       Calcium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       130    130       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       142    142       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       142    142       Zinc 2; catalytic.
FT                                {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       177    177       Zinc 2; catalytic.
FT                                {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       205    205       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       292    292       Zinc 2; catalytic.
FT                                {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       307    307       Calcium. {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   METAL       311    311       Calcium. {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   SITE        291    291       Transition state stabilizer.
FT                                {ECO:0000303|PubMed:15280041,
FT                                ECO:0000303|PubMed:17608735}.
FT   DISULFID    290    295       {ECO:0000269|PubMed:15388919,
FT                                ECO:0000269|PubMed:9048953}.
FT   MUTAGEN     176    176       E->A: KM halves (0.33 mM), kcat reduces
FT                                by 5 orders of magnitude.
FT                                {ECO:0000269|PubMed:15280041}.
FT   MUTAGEN     176    176       E->D,Q: KM decreases (to 0.4 mM), kcat
FT                                reduces by 4 orders of magnitude.
FT                                {ECO:0000269|PubMed:15280041}.
FT   MUTAGEN     291    291       Y->A,F,S: Activity decreases about 100-
FT                                fold. {ECO:0000269|PubMed:15280041}.
FT   CONFLICT    185    185       Y -> F (in Ref. 2; AA sequence).
FT   CONFLICT    285    285       Q -> R (in Ref. 5; no nucleotide entry).
FT   HELIX        51     66       {ECO:0000244|PDB:1TKJ}.
FT   TURN         67     70       {ECO:0000244|PDB:1TKJ}.
FT   HELIX        77     93       {ECO:0000244|PDB:1TKJ}.
FT   STRAND       96    104       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      107    115       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      119    130       {ECO:0000244|PDB:1TKJ}.
FT   TURN        140    143       {ECO:0000244|PDB:1TKJ}.
FT   HELIX       144    159       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      165    174       {ECO:0000244|PDB:1TKJ}.
FT   HELIX       176    178       {ECO:0000244|PDB:1TKJ}.
FT   HELIX       181    189       {ECO:0000244|PDB:1TKJ}.
FT   HELIX       192    195       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      198    204       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      215    217       {ECO:0000244|PDB:1TKF}.
FT   HELIX       221    233       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      239    241       {ECO:0000244|PDB:1TKF}.
FT   HELIX       250    255       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      260    264       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      268    270       {ECO:0000244|PDB:1TKJ}.
FT   HELIX       273    279       {ECO:0000244|PDB:1TKJ}.
FT   STRAND      285    287       {ECO:0000244|PDB:1TKJ}.
FT   TURN        289    292       {ECO:0000244|PDB:1TKJ}.
FT   HELIX       303    321       {ECO:0000244|PDB:1TKJ}.
SQ   SEQUENCE   445 AA;  45940 MW;  6B42B63191F700C9 CRC64;
     MRPNRFSLRR SPTAVAAVAL AAVLAAGAPA AQAAGAAAPT AAAAAAPDIP LANVKAHLTQ
     LSTIAANNGG NRAHGRPGYK ASVDYVKAKL DAAGYTTTLQ QFTSGGATGY NLIADWPGGD
     PNKVLMAGAH LDSVSSGAGI NDNGSGSAAV LETALAVSRA GYQPDKHLRF AWWGAEELGL
     IGSKYYVNNL PSADRSKLAG YLNFDMIGSP NPGYFVYDDD PVIEKTFKDY FAGLNVPTEI
     ETEGDGRSDH APFKNVGVPV GGLFTGAGYT KSAAQAQKWG GTAGQAFDRC YHSSCDSLSN
     INDTALDRNS DAAAHAIWTL SSGTGEPPTG EGVFSNTTDV AIPDAGAAVT SSVAVTGRTG
     NAPAALQVGV DIKHTYRGDL VVDLLAPDGT AYRLKNSSSG DSADNVIATY TVNASSEVAN
     GSWKLRVQDI ARQDTGYIDS WKLTF
//
